-
Something wrong with this record ?
Effectiveness of β-blockers in physically active patients with hypertension: protocol of a systematic review
D. Tučková, M. Klugar, E. Sovová, M. Sovová, L. Štégnerová,
Language English Country Great Britain
Document type Journal Article, Meta-Analysis, Review, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Nursing & Allied Health Database (ProQuest)
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
Family Health Database (ProQuest)
from 2011-01-01
Psychology Database (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
- MeSH
- Adrenergic beta-Antagonists adverse effects therapeutic use MeSH
- Hypertension therapy MeSH
- Drug Therapy, Combination MeSH
- Humans MeSH
- Exercise Therapy MeSH
- Treatment Outcome MeSH
- Research Design MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Meta-Analysis MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
INTRODUCTION: Based on more than 5 decades of epidemiological studies, it is now widely accepted that higher physical activity patterns and levels of cardiorespiratory fitness are associated with better health outcomes. Therefore, it is necessary to consider how treatment methods affect these two components. Clinically, one very important question concerns the influence of aerobic performance on patients being treated for hypertension. The administration of β-blockers can significantly reduce maximal-and especially submaximal-aerobic exercise capacity. The objective of this review is to determine, by comparison of existing mono and combination therapy, which β-blockers are less physically limiting for patients with hypertension who are physically active. METHODS: A three-step strategy will be adopted in the review, following the methods used by the Joanna Briggs Institute (JBI). The initial search will be conducted using the MEDLINE and EMBASE databases. The second search will involve the listed databases for the published literature (MEDLINE, Biomedica Czechoslovaca, Tripdatabase, Pedro, EMBASE, the Cochrane Central Register of Controlled Trials, Cinahl, WoS) and the unpublished literature (Open Grey, Current Controlled Trials, MedNar, ClinicalTrials.gov, Cos Conference Papers Index, the International Clinical Trials Registry Platform of the WHO). Following the JBI methodology, analysis of title/abstracts and full texts, critical appraisal and data extraction will be carried out on selected studies using the JBI tool, MAStARI. This will be performed by two independent reviewers. If possible, statistical meta-analysis will be pooled. Statistical heterogeneity will be assessed. Subgroup analysis will be used for different age and gender characteristics. Funnel plots, Begg's rank correlation and Egger's regression test will be used to detect or correct publication bias. ETHICS AND DISSEMINATION: The results will be disseminated by publishing in a peer-reviewed journal. Ethical assessment is not needed-we will search/evaluate the existing sources of literature. TRIAL REGISTRATION NUMBER: CRD42015026914.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017203
- 003
- CZ-PrNML
- 005
- 20191218101135.0
- 007
- ta
- 008
- 180515s2016 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/bmjopen-2015-010534 $2 doi
- 035 __
- $a (PubMed)27311904
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Tučková, Dagmar $u Department of Social Medicine and Public Health, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic The Czech Republic (Middle European) Centre for Evidence-Based Health Care: An affiliated Centre of the Joanna Briggs Institute, Department of Social Medicine and Public Health, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic. $7 xx0235308
- 245 10
- $a Effectiveness of β-blockers in physically active patients with hypertension: protocol of a systematic review / $c D. Tučková, M. Klugar, E. Sovová, M. Sovová, L. Štégnerová,
- 520 9_
- $a INTRODUCTION: Based on more than 5 decades of epidemiological studies, it is now widely accepted that higher physical activity patterns and levels of cardiorespiratory fitness are associated with better health outcomes. Therefore, it is necessary to consider how treatment methods affect these two components. Clinically, one very important question concerns the influence of aerobic performance on patients being treated for hypertension. The administration of β-blockers can significantly reduce maximal-and especially submaximal-aerobic exercise capacity. The objective of this review is to determine, by comparison of existing mono and combination therapy, which β-blockers are less physically limiting for patients with hypertension who are physically active. METHODS: A three-step strategy will be adopted in the review, following the methods used by the Joanna Briggs Institute (JBI). The initial search will be conducted using the MEDLINE and EMBASE databases. The second search will involve the listed databases for the published literature (MEDLINE, Biomedica Czechoslovaca, Tripdatabase, Pedro, EMBASE, the Cochrane Central Register of Controlled Trials, Cinahl, WoS) and the unpublished literature (Open Grey, Current Controlled Trials, MedNar, ClinicalTrials.gov, Cos Conference Papers Index, the International Clinical Trials Registry Platform of the WHO). Following the JBI methodology, analysis of title/abstracts and full texts, critical appraisal and data extraction will be carried out on selected studies using the JBI tool, MAStARI. This will be performed by two independent reviewers. If possible, statistical meta-analysis will be pooled. Statistical heterogeneity will be assessed. Subgroup analysis will be used for different age and gender characteristics. Funnel plots, Begg's rank correlation and Egger's regression test will be used to detect or correct publication bias. ETHICS AND DISSEMINATION: The results will be disseminated by publishing in a peer-reviewed journal. Ethical assessment is not needed-we will search/evaluate the existing sources of literature. TRIAL REGISTRATION NUMBER: CRD42015026914.
- 650 _2
- $a beta blokátory $x škodlivé účinky $x terapeutické užití $7 D000319
- 650 _2
- $a kombinovaná farmakoterapie $7 D004359
- 650 _2
- $a terapie cvičením $7 D005081
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypertenze $x terapie $7 D006973
- 650 _2
- $a výzkumný projekt $7 D012107
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Klugar, Miloslav, $u Department of Social Medicine and Public Health, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic The Czech Republic (Middle European) Centre for Evidence-Based Health Care: An affiliated Centre of the Joanna Briggs Institute, Department of Social Medicine and Public Health, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic. $d 1982- $7 mzk2015879957
- 700 1_
- $a Sovová, Eliška, $u Department of Exercise Medicine and Cardiovascular Rehabilitation, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic. $d 1960- $7 mzk2004257426
- 700 1_
- $a Sovová, Markéta $u Department of Internal Medicine II - Gastroenterology and Hepatology, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic. $7 xx0224226
- 700 1_
- $a Štégnerová, Lenka $u Department of Exercise Medicine and Cardiovascular Rehabilitation, Faculty of Medicine and Dentistry, Palacký University in Olomouc, Olomouc, Czech Republic. $7 xx0224184
- 773 0_
- $w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 6, č. 6 (2016), s. e010534
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27311904 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20191218101442 $b ABA008
- 999 __
- $a ok $b bmc $g 1300827 $s 1014043
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 6 $c 6 $d e010534 $e 20160615 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
- LZP __
- $a Pubmed-20180515